These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9601114)

  • 41. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast and cervical cancer screening disparities associated with disability severity.
    Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
    Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Equity in prevention and health care.
    Lorant V; Boland B; Humblet P; Deliège D
    J Epidemiol Community Health; 2002 Jul; 56(7):510-6. PubMed ID: 12080158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Which factors influence screening practices for female cancer in France?].
    Duport N; Serra D; Goulard H; Bloch J
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):303-13. PubMed ID: 18951740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening program serves fraction of those eligible.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Feb; 99(4):270-1. PubMed ID: 17312302
    [No Abstract]   [Full Text] [Related]  

  • 46. [Human Development Index and secondary prevention of breast and cervical cancer: an ecological study].
    Sadovsky AD; Poton WL; Reis-Santos B; Barcelos MR; Silva IC
    Cad Saude Publica; 2015 Jul; 31(7):1539-50. PubMed ID: 26248108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional variations in cancer screening rates found in women with diabetes.
    Marshall JG; Cowell JM; Campbell ES; McNaughton DB
    Nurs Res; 2010; 59(1):34-41. PubMed ID: 20010043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do general practitioners influence the uptake of breast cancer screening?
    Majeed FA; Cook DG; Given-Wilson R; Vecchi P; Poloniecki J
    J Med Screen; 1995; 2(3):119-24. PubMed ID: 8536178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demographic predictors of clinical breast examination, mammography, and Pap test screening among older women.
    Sherman JJ; Abel E; Tavakoli A
    J Am Acad Nurse Pract; 1996 May; 8(5):231-6. PubMed ID: 8788735
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population.
    Guilcher SJ; Newman A; Jaglal SB
    J Womens Health (Larchmt); 2010 Jan; 19(1):57-63. PubMed ID: 20088659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers.
    Castellano PZ; Wenger NK; Graves WL
    J Womens Health Gend Based Med; 2001 Jun; 10(5):451-61. PubMed ID: 11445044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour.
    Massat NJ; Douglas E; Waller J; Wardle J; Duffy SW
    BMJ Open; 2015 Jul; 5(7):e007735. PubMed ID: 26209119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of ENCOREplus. A community-based breast and cervical cancer screening program.
    Fernandez ME; DeBor M; Candreia MJ; Wagner AK; Stewart KR
    Am J Prev Med; 1999 Apr; 16(3 Suppl):35-49. PubMed ID: 10198679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response by women aged 65-79 to invitation for screening for breast cancer by mammography: a pilot study.
    Hobbs P; Kay C; Friedman EH; St Leger AS; Lambert C; Boggis CR; Howard TM; Owen AW; Asbury DL
    BMJ; 1990 Dec; 301(6764):1314-6. PubMed ID: 2271857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of self-reported breast and cervical cancer screening tests among low-income minority women.
    Paskett ED; Tatum CM; Mack DW; Hoen H; Case LD; Velez R
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):721-6. PubMed ID: 8877064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mobile Mammography Participation Among Medically Underserved Women: A Systematic Review.
    Vang S; Margolies LR; Jandorf L
    Prev Chronic Dis; 2018 Nov; 15():E140. PubMed ID: 30447104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contradictions in women's health care provision: a case study of attendance for breast cancer screening.
    Ross NA; Rosenberg MW; Pross DC; Bass B
    Soc Sci Med; 1994 Oct; 39(8):1015-25. PubMed ID: 7809655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attitude or access: reasons for not attending mammography in Northern Ireland.
    Kee F; Telford AM; Donaghy P; O'Doherty A
    Eur J Cancer Prev; 1992 Jun; 1(4):311-5. PubMed ID: 1467780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.